Medindia

X

Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404

by Medindia Content Team on  December 10, 2006 at 1:44 PM General Health News   - G J E 4
Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
An U.S based Drug manufacturer, Compellis Pharmaceuticals, has been granted the PATENT for CP404, a nasal spray that combats obesity entitled "Inhibition of olfactory neurosensory function to treat obesity and related disorders." Compellis Pharmaceuticals is a biopharmaceutical company focusing more on developing novel mechanism-based therapeutics for treating obesity.
Advertisement

The company describes CP404 as "therapeutic platform for treating obesity" as it has already produced "significant weight loss" in animals. The results of the Pre-clinical animal models were published in Pharmacology, Biochemistry and Behavior.

Advertisement
Chris Adams, president and chief executive officer of Compellis Pharmaceuticals says that the PATENT for CP404 marks a significant milestone in the company's history as it the first issued PATENT protecting the therapeutic platform for treating obesity and also added that the company would begin human testing by 2007.

CP404 works as a calcium channel blocker, blocking the senses of smell and taste. It is taken in a nasal formulation to block olfactory activity and lessen food intake.

Source: Medindia
SRI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All